CARDIOVASCULAR
hamburger

Patient Education

Patients with advanced heart failure may not fully grasp that heart failure is a serious, progressive disease. They may not realize how sick they truly are until it’s too late.

You can help your patients understand if HeartMate 3™ LVAD therapy might be a treatment option before their heart failure worsens, giving them more time to decide and plan for treatment.

Here are a few points you might want to share with your patients:

  • LVAD therapy is an option for patients with NYHA Class IIIB-IV heart failure
  • HeartMate 3 LVAD is a small implantable pump that is designed to help their heart pump blood
  • There have been significant clinical advancements in LVAD therapy, with HeartMate 3 LVAD survival rate now comparable to heart transplant at 2 years1,2*
  • HeartMate 3 LVAD has an excellent safety profile, with reduced stroke and pump thrombosis adverse events rates3

View MOMENTUM 3 Trial Data

Resources to Support Patient Discussion

  • Pre-Implant Patient Education Videos

Patient Education Brochure

This brochure defines heart failure (HF) and describes its various stages and classes. It also presents potential treatments for HF, introducing the HeartMate 3 LVAD.

HeartMate 3 Left Ventricular Assist Device (LVAD) Patient Guide

This guide helps patients and caregivers become familiar with the HeartMate 3 LVAD upon hospital discharge.

*Based on published data from separate datasets, which may involve different patient populations and other variables. Not a head-to-head comparison. Data presented for informational purposes only.

References

  1. Teuteberg JJ, Cleveland JC, Cowger J, Higgins RS, et al. The Society of Thoracic Surgeons Intermacs 2019 Annual Report: the changing landscape of devices and indications. Ann Thorac Surg. 2020;109:649-660.
  2. Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplant Report-2018: Focus Theme: Multiorgan Transplantation. J Heart Lung Transplant 2018:37:1155-1168.
  3. Mehra MR, Uriel N, Naka Y, et al. A Fully Magnetically Levitated Ventricular Assist Device-Final Report. N Engl J Med. 2019;380:1618-1627.
Indications, Safety & Warnings

MAT-2012376 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.